Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Breddin

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
Seminars in Thrombosis and Hemostasis|November 5, 1999
Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosisB Kaiser, C M Kirchmaier, H K Breddin, et al.
Thrombosis Research|March 1, 1993
Functional studies on platelets of a patient with an acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIB/IIIA complexP Spangenberg, C M Kirchmaier, A Schirmer, et al.
Thrombosis Research|July 15, 1990
Effects of human elastase on von Willebrand factor in highly purified factor VIII concentrate and in cryoprecipitateM Jeleńska, W Bykowska, M Kopeć, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1985
PARD: platelet aggregation as a risk factor in diabetics: results of a prospective studyH K Breddin, H J Krzywanek, P Althoff, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|April 1, 1995
Effects of 0-/-B-hydroxyethyl/rutoside on platelet function and thrombus formation in rat mesenteric vesselsK Krupiński, H K Breddin, J Giedrojć, et al.
International Angiology : a Journal of the International Union of Angiology|November 20, 1998
Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study GroupC M Kirchmaier, H Wolf, H Schäfer, et al.
Thrombosis Research|February 15, 1991
Fibrinogen does not protect von Willebrand factor against proteolysis by human cathepsin GM Jeleńska, M Kopeć, I Sopata, et al.
Journal of Cardiovascular Pharmacology|September 2, 1999
Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal modelJ Giedrojć, M Klimiuk, P Radziwon, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|April 21, 1999
Experimental studies on the anticoagulant and antithrombotic effects of sodium and calcium pentosan polysulphateJ Giedrojć, P Radziwon, M Klimiuk, et al.
Thrombosis Research|August 15, 1993
The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal modelsP Bacher, J M Walenga, O Iqbal, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Seminars in Thrombosis and Hemostasis|November 5, 1999
Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosisB Kaiser, C M Kirchmaier, H K Breddin, et al.
Thrombosis Research|March 1, 1993
Functional studies on platelets of a patient with an acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIB/IIIA complexP Spangenberg, C M Kirchmaier, A Schirmer, et al.
Thrombosis Research|July 15, 1990
Effects of human elastase on von Willebrand factor in highly purified factor VIII concentrate and in cryoprecipitateM Jeleńska, W Bykowska, M Kopeć, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1985
PARD: platelet aggregation as a risk factor in diabetics: results of a prospective studyH K Breddin, H J Krzywanek, P Althoff, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|April 1, 1995
Effects of 0-/-B-hydroxyethyl/rutoside on platelet function and thrombus formation in rat mesenteric vesselsK Krupiński, H K Breddin, J Giedrojć, et al.
International Angiology : a Journal of the International Union of Angiology|November 20, 1998
Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study GroupC M Kirchmaier, H Wolf, H Schäfer, et al.
Thrombosis Research|February 15, 1991
Fibrinogen does not protect von Willebrand factor against proteolysis by human cathepsin GM Jeleńska, M Kopeć, I Sopata, et al.
Journal of Cardiovascular Pharmacology|September 2, 1999
Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal modelJ Giedrojć, M Klimiuk, P Radziwon, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|April 21, 1999
Experimental studies on the anticoagulant and antithrombotic effects of sodium and calcium pentosan polysulphateJ Giedrojć, P Radziwon, M Klimiuk, et al.
Thrombosis Research|August 15, 1993
The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal modelsP Bacher, J M Walenga, O Iqbal, et al.
Pageof 22